a clinical stage biopharmaceutical company
Industry Biotechnology
A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.
Ticker / NAME | Correlation To AVTX | 1D Price Change % | ||
---|---|---|---|---|
AVTX | 100% | +13.00% | ||
FGEN - AVTX | 57% Loosely correlated | -9.19% | ||
XLO - AVTX | 35% Loosely correlated | -13.63% | ||
CERO - AVTX | 30% Poorly correlated | -9.28% | ||
RLYB - AVTX | 27% Poorly correlated | -4.35% | ||
CELC - AVTX | 27% Poorly correlated | -2.13% | ||
More |
Ticker / NAME | Correlation To AVTX | 1D Price Change % |
---|---|---|
AVTX | 100% | +13.00% |
AVTX (2 stocks) | 99% Closely correlated | +1.88% |
biopharmaceuticals (52 stocks) | 26% Poorly correlated | +2.00% |
pharmaceuticals (167 stocks) | 15% Poorly correlated | +0.82% |